Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18337733.
- Also identified by DOI 10.1038/nrc2346.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The importance of multidisciplinary translational clinical trials is obvious; however, making them work is complex and challenging. Here I present an argument for designing and implementing multidisciplinary mechanistic trials and present the lessons our team at the Massachusetts General Hospital Cancer Center has learned from two such trials in cancer patients with locally advanced rectal carcinomas and recurrent glioblastomas.
Medical subject headings
- Angiogenesis Inhibitors
- Neoplasms
- Neovascularization, Pathologic